oral version of semaglutide A new Wegovy has been FDA-approved, offering a more affordable and accessible option to injectable GLP-1 medications that have transformed weight loss treatment for millions. Read the full story Everything You Need To Know

In clinical trials and other studies, those drugs outperform liraglutide, producing substantially more weight loss while causing fewer side effects

In many studies, participants had an average weight loss of 15% to 20% from where they started

The most commonly reported side effects of Rybelsus include: Gastrointestinal disturbances nausea (very common, affecting more than 1 in 10 patients), vomiting, diarrhoea, abdominal pain, constipation, and dyspepsia (common, affecting up to 1 in 10 patients) Decreased appetite (common) often contributing to weight loss Hypoglycaemia (common) particularly when used in combination with insulin or sulfonylureas

Monitor Symptoms : Report any severe or persistent side effects to your doctor

These changes may indicate contamination or degradation